In this podcast we speak with Dr Hakim-Moulay Dehbi, who is currently Head of Statistics at the Comprehensive Clinical Trials Unit at UCL, about his last paper on controlled backfill in oncology dose-finding trials. He tells us about the motivation for this work, and more importantly how the interests of patients with cancer need to be taken into account in dose-finding designs. For more information and to access the transcript: www.ucl.ac.uk/statistics/ Date of episode recording: 2022-04-2 Duration: 00:18:16 Language of episode: English Presenter: Nathan Green Guests: Hakim-Moulay Dehbi Producer: Nathan Green
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News